Comprehensive analysis of cuproptosis-related lncRNAs in the prognosis and therapy response of patients with bladder cancer.

Ding Li,Xuan Wu,Xinxin Fan,Cheng Cheng,Dongbei Li,Wenzhou Zhang

Annals of translational medicine（2022）

引用 1|浏览3

暂无评分

摘要

Our study established and verified a novel clinical risk signature with cuproptosis-related lncRNAs that may predict therapy response and prognosis with robust and stable accuracy in patients with BLCA and enhance the personalized management of this patient population.

查看译文

关键词

Bladder cancer (BLCA),cuproptosis,drug sensitivity,long noncoding RNAs (lncRNA),risk signature

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要